RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

RTALB

SUMMARY FINANCIALS

(*) The information on this page is updated with a delay. The home page or search functions on the site should be used for instant data tracking.

(**) The following data includes some selected items from the companys/funds financial statements. It is necessary to use the search functions on the site for complete financial statements.

(***) The table below contains the data in the "current period" column of financial statements published lastly on the KAP system for the relevant year and period, and the adjustments/corrections made in the "previous period" information are not taken into account when publishing the tables for the relevant current year and period. To reach the data containing this detail, the financial report notification of the company should be used.

Statement of Financial Position (Balance Sheet)
2020/12
2021/12
2022/12
2023/12
Presentation Currency
TL
TL
TL
TL
Nature of Financial Statements
Consolidated
Consolidated
Consolidated
Unconsolidated
Current Assets
142.975.224
369.386.906
300.531.007
249.154.843
Non-current Assets
113.549.713
183.016.909
439.682.176
1.034.798.177
Total Assets
256.524.937
552.403.815
740.213.183
1.283.953.020
Current Liabilities
82.514.463
204.880.109
88.585.131
88.819.359
Non-current Liabilities
6.204.278
4.289.428
18.888.286
75.312.271
Total Liabilities
88.718.741
209.169.537
107.473.417
164.131.630
Equity Attributable to Owners of Parent
150.274.976
312.673.589
594.520.996
1.119.821.390
Issued Capital
41.000.000
42.970.214
100.000.000
100.000.000
Non-controlling Interests
17.531.220
30.560.689
38.218.770
0
Total Equity
167.806.196
343.234.278
632.739.766
1.119.821.390
Total Liabilities and Equity
256.524.937
552.403.815
740.213.183
1.283.953.020

Statement of Profit or Loss and Other Comprehensive Income
2020/12
2021/12
2022/12
2023/12
Presentation Currency
TL
TL
TL
TL
Nature of Financial Statements
Consolidated
Consolidated
Consolidated
Unconsolidated
Revenue
230.441.888
384.341.641
86.025.988
95.936.328
Cost of Sales
-119.539.151
-228.211.294
-50.374.366
-78.024.891
Gross Profit (Loss) from Commercial Operations
110.902.737
156.130.347
35.651.622
17.911.437
Revenue from Finance Sector Operations
Cost of Finance Sector Operations
Gross Profit (Loss) from Finance Sector Operations
Gross Profit (Loss)
110.902.737
156.130.347
35.651.622
17.911.437
Profit (Loss) From Operating Activities
49.323.222
92.659.782
43.438.413
-15.276.945
Profit (Loss) Before Financing Income (Expense)
89.266.628
153.302.794
317.619.880
13.814.512
Profit (Loss) from Continuing Operations, Before Tax
87.988.991
147.359.697
302.476.928
-72.561.158
Profit (Loss) from Continuing Operations
78.398.129
127.300.637
287.938.191
-71.452.011
Profit (Loss) from Discontinued Operations
Net Profit (Loss)
78.398.129
127.300.637
287.938.191
-71.452.011
Profit (Loss) Attributable To, Non-controlling Interests
17.464.890
12.826.969
6.821.185
0
Profit (Loss) Attributable To, Owners of Parent
60.933.239
114.473.668
281.117.006
-71.452.011
Other Comprehensive Income (Loss)
1.234.234
9.315
-327.679
814.660
Total Comprehensive Income (Loss)
79.632.363
127.309.952
287.610.512
-70.637.351
Total Comprehensive Income Attributable To, Non-controlling Interests
17.464.890
12.826.969
6.821.185
0
Total Comprehensive Income Attributable To, Owners of Parent
62.167.473
114.482.983
280.789.327
-70.637.351

Create Word File Create Excel File Print